What improvements would you like in Yahoo! Finance Message Boards? Please send us feedback.
Message Boards Settings Rosetta Genomics, Ltd. (ROSG) - Quote Info
colon cancer      2-Nov-09 10:03 am    
Rosetta Genomics (NASDAQ:ROSG) today announced an update regarding their colon cancer diagnostic program and said that Ayelet Chajut, Executive Vice President, R&D, Head of Molecular Biology will speak more about this program at the 6th International Conference on Circulating Nucleic Acids in Plasma and Serum (CNAPS-VI). The conference will held from November 9 to November 11 in Hong Kong where they will present a new generation of molecular diagnostic markers that will help in the treatment and diagnosis of colon cancer. Rosetta Genomics is one of the leading molecular diagnostics companies that develops and commercializes molecular diagnostic products based on its proprietary microRNAs. The company is also developing and discovering early detection cancer screening products, including a colon cancer screening test.
http://www.favstocks.com/rosetta-genomic... Rosetta Genomics have their labs in Philadelphia where they perform commercial molecular diagnostics tests in order to discover and develop new diagnostics markers.
Rating :
 (No ratings)
Rate it:
awful/not related to \pooraveragegoodexcellent

viratk29


View Messages

Ignore User

Report Abuse

< Previous Message |   Next Message >
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Messages in Topic

Minimum rating: What's this?
  Subject Author Rating Time of Post (ET)  
 
colon cancer
viratk29 Not rated 2-Nov-09 10:03 am  
 
*New Member as of today and escond post spamming f...
lymezhome Rate it 2-Nov-09 02:09 pm  
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Rosetta Genomics, Ltd. (ROSG)

Chart for Rosetta Genomics, Ltd. (ROSG)
On Nov 27: 2.05 Down 0.05 (2.38%)
Symbol Lookup